@ARTICLE{
author={Fleischmann Roy M,Damjanov Nemanja S,Kivitz Alan J,Legedza Anna,Hoock Thomas,Kinnman Nils},
year={2015},
title={A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={67},
number={2},
pages={334-343},
document_type={Article},
} 

@ARTICLE{
author={Fleischmann Roy M,Spencer-Green George T,Fan Frank,Frankovic Biliana,Luo Xia,Hoock Thomas,Damjanov Nemanja S},
year={2011},
title={Dose Ranging Study of VX-509, An Oral Selective JAK3 Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis (RA).},
journal={ARTHRITIS AND RHEUMATISM},
volume={63},
number={12},
pages={4042-4042},
document_type={Meeting Abstract},
} 

